Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03335540
Title An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

Advanced Solid Tumor

Therapies

BMS-986205 + Nivolumab

Nivolumab + Relatlimab

Cabiralizumab + Nivolumab

Lirilumab + Nivolumab

BMS-986156 + Nivolumab

Ipilimumab + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 0001 Chicago Illinois 60637 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Local Institution - 0002 Baltimore Maryland 21287 United States Details
Local Institution - 0003 Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field